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Abstract

Key Points

BACKGROUND More than 1.2 billion adults worldwide have hypertension. High retention in clinical
care is essential for long-term management of hypertension, but 1-year retention rates are less than
50% in many resource-limited settings.

Question What are characteristics and
patterns of retention in hypertension
care in primary care settings in Nigeria?
Findings In this cohort study of 10 686

OBJECTIVE To evaluate short-term retention rates and associated factors among patients with

patients with hypertension at 60

hypertension in primary health care centers in the Federal Capital Territory of Nigeria.

primary health care centers, the
3-month rolling average 37-day

DESIGN, SETTING, AND PARTICIPANTS In this cohort study, data were collected by trained study

retention rate was 41%, with wide

staff from adults aged 18 years or older at 60 public, primary health care centers in Nigeria between

variability among centers. The retention

January 2020 and July 2021 as part of the Hypertension Treatment in Nigeria (HTN) Program.

rate was higher among patients who

Patients with hypertension were registered.

were older, were female, had a higher
body mass index, lived in the Kuje area
council, received hypertension

EXPOSURES Follow-up visit for hypertension care within 37 days of the registration visit.

treatment at the registration visit, and

MAIN OUTCOMES AND MEASURES The main outcome was the 3-month rolling average 37-day

were registered during the

retention rate in hypertension care, calculated by dividing the number of patients who had a

postintervention period.

follow-up visit within 37 days of their first (ie, registration) visit in the program by the total number of
registered patients with hypertension during multiple consecutive 3-month periods. Interrupted
time series analyses evaluated trends in retention rates before and after the intervention phase of
the HTN Program. Mixed-effects, multivariable regression models evaluated associations between
patient-, site-, and area council–level factors, hypertension treatment and control status, and 37-day

Meaning The findings suggest that
retention in hypertension care is
suboptimal in primary health care
centers in Nigeria, although variability
among sites was found.

retention rate.
RESULTS In total, 10 686 patients (68.3% female; mean [SD] age, 48.8 [12.7] years) were included
in the analysis. During the study period, the 3-month rolling average 37-day retention rate was 41%
(95% CI, 37%-46%), with wide variability among sites. The retention rate was higher among patients

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

who were older (adjusted odds ratio [aOR], 1.01 per year; 95% CI, 1.01-1.02 per year), were female
(aOR, 1.11; 95% CI, 1.01-1.23), had a higher body mass index (aOR, 1.01; 95% CI, 1.00-1.02), were in the
Kuje vs the Abaji area council (aOR, 2.25; 95% CI, 1.25-4.04), received hypertension treatment at the
registration visit (aOR, 1.27; 95% CI, 1.07-1.50), and were registered during the postintervention
period (aOR, 1.16; 95% CI, 1.06-1.26).
CONCLUSIONS AND RELEVANCE The findings suggest that retention in hypertension care is
suboptimal in primary health care centers in Nigeria, although large variability among sites was
(continued)
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Abstract (continued)

found. Potentially modifiable and nonmodifiable factors associated with retention were identified
and may inform multilevel, contextualized implementation strategies to improve retention.
JAMA Network Open. 2022;5(9):e2230025. doi:10.1001/jamanetworkopen.2022.30025

Introduction
Elevated blood pressure is a leading modifiable factor associated with cardiovascular disease
morbidity and mortality in high-income countries, such as the US, and in low- and middle-income
countries.1,2 Approximately 1.28 billion adults aged 30 to 79 years worldwide have hypertension, and
two-thirds live in low- and middle-income countries.3 Nigeria is the most populous country in Africa
and has an estimated hypertension prevalence of 38%, with suboptimal hypertension awareness
(60%), treatment (34%), and control (12%) rates.4 Nigeria has set a national goal of reducing the risk
of premature mortality from noncommunicable diseases by one-third by 2030.5 To reduce the risk
of hypertension-related diseases and to improve healthy life expectancy, hypertension care in
Nigeria is transitioning from secondary and tertiary care centers to primary health care centers
(PHCs) to improve the reach, effectiveness, implementation, and maintenance of hypertensive
services, as recommended by the World Health Organization (WHO) healthy lifestyle counseling,
evidence-based treatment protocols, access to essential medicines and technology, risk-based
cardiovascular disease management, team-based care, and systems for monitoring (HEARTS)
technical package.6,7 This multilevel intervention includes (1) a standard treatment protocol (national
policy level), (2) patient registration and empanelment (health system level), (3) encouragement of
fixed-dose combination therapy (health system level), (4) incentivized team-based care (health care
worker level), and (5) home blood pressure monitoring and health coaching (patient level). The
Hypertension Treatment in Nigeria (HTN) Program was created to implement and evaluate a
culturally and contextually adapted, large-scale, evidence-based implementation package to
improve the cascade of hypertension care in public PHCs in the Federal Capital Territory of Nigeria.
Retention to hypertension care is defined as patients’ regular engagement with medical care at
a health care facility. High retention is essential for long-term management of hypertension and
programmatic maintenance, but 1-year retention rates are less than 50% in many resource-limited
settings.8 Optimizing retention in care is a central objective of the HTN Program because
longitudinal, patient-centered care is essential for sustained hypertension control. Primary care
services may be limited in scope, resources, and staff training to achieve high retention rates, and the
COVID-19 pandemic has further threatened the hypertension care cascade from diagnosis to
treatment and subsequent control.9 Despite the importance of retention in the hypertension care
cascade, few studies have comprehensively described the characteristics and patterns of retention in
hypertension care in primary care settings.10-12
This study aimed to describe the characteristics and patterns of short-term retention (follow-up
ⱕ37 days to match international and national guidelines)13,14 in hypertension care in public PHCs in
the Federal Capital Territory of Nigeria that are part of the HTN Program. We also sought to identify
potentially modifiable factors associated with retention that would be the targets for multilevel,
contextualized implementation strategies to improve patient adherence to hypertension care.

Methods
Ethics Review and Informed Consent
The protocol for this cohort study was reviewed and approved by the ethics boards of the University
of Abuja Teaching Hospital, Federal Capital Territory of Nigeria, and Northwestern University, as well
as the HTN Program’s data and safety monitoring board. Patient informed consent was waived based
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on the Common Rule. This study followed the Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) reporting guideline.15

Study Design and Population
This study was embedded within the HTN Program, which is a prospective, longitudinal, type-2
hybrid implementation-effectiveness research study. The HTN Program aims to evaluate the
implementation and effectiveness of a multilevel, evidence-based implementation package using an
interrupted time series design.16 The research team conducted a service availability and readiness
assessment in 2019, and a multistage random sampling frame was used to select eligible PHCs based
on geographic representation and population size, with additional sites selected after consultation
with the Nigerian Federal Ministry of Health and the Federal Capital Territory’s Primary Health Care
Board. Sixty PHCs were invited to participate in the HTN Program, and all agreed to participate.
Details about the HTN Program are reported elsewhere.17,18
The current study included 19 months of data from the HTN Program, among which the first 11
months (January to November 2020) represent the preintervention, or baseline control, period and
the remaining 8 months (December 2020 to July 2021) represent the postintervention period.
Follow-up data from August to October 2021 were also included to evaluate retention and follow-up
patterns within 3 months after baseline registration from January 2020 to July 2021. The multilevel
implementation package was based on the Kaiser Permanente Northern California model19 and the
WHO HEARTS technical package.7 Frontline health care staff are compensated for registration of
patients through monthly stipends of at least 10 000 naira (USD 24) each. The home blood pressure
monitoring and health coaching intervention will be implemented in the third quarter of 2022.
Starting in January 2021, blood pressure–lowering medications were made freely available to
patients in 30-day supplies as part of the development of a drug revolving fund for the sustainment
of a reliable supply of quality medications.
Despite the recognized clinical and programmatic importance of retention, there is no
recognized standard measure for retention in care. Measuring retention is complex because it
includes multiple visits, scheduled at varying time intervals, and occurring across time. There are
many ways to define and operationalize retention in care, and studies have used a wide range of
approaches.20 This study focused on the retention between the registration visit and the first
follow-up visit within 37 days based on the WHO and Nigeria national hypertension guidelines, both
of which recommend 1-month follow-up.13,14 We chose 37 days rather than 1 month or 30 days as
the primary time point to measure retention for the following reasons: (1) patients were typically
prescribed 30-day treatment regimens; (2) documentation of patient registration and medical
records was paper based, and the record information officers needed time to manually enter the data
into REDCap; (3) the research team conducted biweekly data status and quality reports checks to
identify missing and low-quality data, and the respective site-level record information officers
verified or corrected data based on these reports, which may have had time lags or delays;21 and (4)
although practitioners informed each patient to follow up in 1 month or 30 days, the current study
used a modestly longer window to avoid misclassifying patients who followed up just beyond the
recommended period. Although longer (eg, 90-day) prescriptions have been recommended to
improve hypertension control,22 the out-of-pocket costs for longer treatment regimens make this
infeasible for many Nigerians.23
We developed monthly, automated audit and feedback reports (eFigure 1 in the Supplement) to
assess study quality and performance and a real-time registry dashboard for patient follow-up
tracking; these were designed to improve retention through patient empanelment. The audit and
feedback reports provided information on a 3-month rolling basis, including (1) the number of newly
registered patients by month, (2) the number of days since the last visit among all registered patients,
(3) the proportion of patients who were treated, (4) the proportion of patients for whom blood
pressure was controlled, (5) patients who should be contacted to return to the PHC, and (6) patients
who should be considered for treatment with a first-line blood pressure–lowering drug at their next
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visit or for an additional medication if already taking a medication. The automated audit and feedback
reports assisted the study team in performing quarterly site-level monitoring and supportive
supervision visits.

Study Population
Sites were instructed to document patient visits and to measure blood pressure twice among all
adults (age ⱖ18 years) who presented to the participating PHC using a standard approach following
centralized training and periodic retraining at the University of Abuja Teaching Hospital. Patients with
hypertension were registered into a longitudinal hypertension registry regardless of the baseline or
intervention period. Consecutive adults with hypertension, defined as (1) a history of hypertension,
(2) persistently elevated systolic blood pressure of 140 mm Hg or above, (3) persistently elevated
diastolic blood pressure of 90 mm Hg or above, and/or (4) use of blood pressure–lowering
medications, were registered at their respective PHC. Persistently elevated blood pressure was
defined based on 2 or more measurements taken at least 1 week apart at respective health centers
based on the 2021 WHO hypertension guideline.22 Patients who had not been previously diagnosed
with hypertension and presented with systolic blood pressure between 140 and 150 mm Hg would
have their blood pressure rechecked in 3 to 7 days for confirmation of persistently elevated blood
pressure. For patients with systolic blood pressure higher than 150 mm Hg, their blood pressure
would be rechecked on the same day within 1 to 3 hours.
After diagnosis of hypertension or a visit to the PHC during the registration period, participant
data were captured on a participant’s treatment card by a trained health care worker at the PHC. The
participant was administered a hypertension treatment card, including a unique hypertension
program identifier, blood pressure, heart rate, body weight, and medications. Participants were
instructed to bring this card to subsequent visits to track their blood pressure over time. Participant
treatment cards were also retained by the PHCs to capture baseline and longitudinal participant
information including demographics, contact information, medical history, blood pressure
measurements, laboratory measures, hypertension medications, and adverse events.24
At subsequent patient visits, diagnosis and treatment cards and paper case report forms were
updated with blood pressure measurements; changes in blood pressure–lowering medications, if
any; and available laboratory data. The research team performed centralized monitoring through
data and status quality reports and REDCap, reporting features to identify missing and low-quality
data, including outliers and data entry errors. The research team reviewed sites’ reports with the
PHCs’ respective record information officers to verify or correct data based on source
document review.

Statistical Analysis
Deidentified descriptive data are reported as means (SDs) and medians (IQRs) for continuous
variables if data were skewed and as proportions (95% CIs) for categorical variables. Data were
analyzed overall and by key subgroups, including by sex, PHC, area council, and calendar month. The
retention, or follow-up, rate was calculated by dividing the number of patients who had a follow-up
visit within a prespecified number of days (ie, 37) after their registration visit by the total number of
registered patients with hypertension. We also assessed retention rates for other time points (ie, 3,
6, and 12 months), but these longer periods are beyond the primary focus of this study. The 3-month
rolling average 37-day retention rate in hypertension care was calculated by dividing the number of
patients who had a follow-up visit within 37 days of their first (ie, registration) visit by the total
number of registered patients with hypertension during multiple consecutive 3-month periods.
Other periods were included as sensitivity analyses.
All analyses were completed using a complete case approach. Interrupted time series analyses
were performed to evaluate linear and nonlinear trends in retention rates before and after the
intervention phase of the HTN Program. We used the root-mean-square error to evaluate the model
fit.25 The intraclass correlation coefficient was used to measure the variability of the retention rates
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among sites. We also created hierarchical mixed-effects, multivariable logistic regression models to
evaluate associations between patient demographics, comorbidities, site, area council–level factors,
hypertension treatment and control, and site-level factors and 37-day retention rates. Unadjusted
and adjusted models are reported. Models were adjusted for age, sex, body mass index (calculated as
weight in kilograms divided by height in meters squared), alcohol use, fixed-dose combination
therapy, and educational level. Random effects modeling was used to account for within-site
clustering. SAS, version 9.4 (SAS Institute) and R, version 4.0.5 (R Project for Statistical Computing)
were used for statistical analyses. A 2-sided P < .05 was used to define statistical significance, and no
adjustments were made for multiple comparisons.

Results
From January 2020 to July 2021, 11 078 unique patients were recruited and registered from 60 PHCs
in 6 area councils. After excluding individuals with missing or erroneous data on age, sex, or blood
pressure or who did not meet diagnostic criteria for hypertension (3.5%), 10 686 patients were
included in the current analysis (eFigure 2 in the Supplement); among these, there were 36 925
unique visits (eTable 1 in the Supplement).
Table 1 reports patients’ demographics and clinical characteristics overall and by sex. The mean
(SD) age was 48.8 (12.7) years; 68.3% of patients were female, 31.7% were male, and 26.6% had
never attended school. Most patients (53.7%) had a history of hypertension, but self-reported

Table 1. Patients’ Sociodemographic and Clinical Characteristics and Blood Pressure Overall and by Sex
Patientsa
Variables

Total
(n = 10 686)

Males
(n = 3390)

Females
(n = 7296)

P value

Age, mean (SD), y

48.8 (12.7)

52.2 (12.0)

47.2 (12.7)

<.001

Pregnant

NA

NA

113 (1.5)

NE

BMI, mean (SD)

27.5 (6.0)

26.4 (4.9)

28.0 (6.3)

<.001

Educational level
Never attended school

2845 (26.6)

572 (16.9)

2273 (31.2)

Primary school

1991 (18.6)

565 (16.7)

1426 (19.5)

Secondary school

2579 (24.1)

773 (22.8)

1806 (24.8)

High school or more

3250 (30.5)

1472 (43.4)

1778 (24.4)

Hypertension

5733 (53.7)

1773 (52.3)

3960 (54.3)

Diabetes

559 (5.2)

175 (5.2)

384 (5.3)

.79

Heart failure

34 (0.3)

11 (0.3)

23 (0.3)

.43

Chronic kidney disease

16 (0.1)

6 (0.2)

10 (0.1)

.99

Stroke

84 (0.8)

48 (1.4)

36 (0.5)

<.001

Heart attack

25 (0.2)

12 (0.4)

13 (0.2)

.21

<.001

Medical history
.046

Smoking
Current

92 (0.9)

69 (2.0)

23 (0.3)

<.001

Former

91 (0.9)

77 (2.3)

14 (0.2)

<.001

Alcohol use
Current

385 (3.6)

271 (8.0)

114 (1.6)

<.001

Former

191 (1.8)

125 (3.7)

66 (0.9)

<.001

Blood pressure, mean (SD), mm Hg
First systolic

157.5 (21.3)

158.7 (20.9)

157.0 (21.5)

<.001

Second systolic

152.0 (20.7)

153.5 (20.2)

151.3 (20.9)

<.001

First diastolic

97.0 (14.0)

96.8 (14.1)

97.1 (13.9)

.37

Second diastolic

94.8 (13.7)

94.6 (13.8)

94.9 (13.7)

.26

83.6 (15.7)

82.0 (13.7)

84.3 (16.4)

<.001

52.0

52.6

51.8

.47

Heart rate, mean (SD), beats per min
b

Walk-in treatment rate, %
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history of comorbid disease, including diabetes (5.2%), heart failure (0.3%), chronic kidney disease
(0.2%), stroke (0.8%), and heart attack (0.2%), was uncommon. The hypertension treatment rate at
the start of the baseline visit was 52.0%. Current smoking was reported in 0.9% of patients, with a
higher smoking rate among males compared with females (2.0% vs 0.3%; P < .001). The mean (SD)
body mass index was higher among females compared with males (28.0 [6.3] vs 26.4 [4.9];
P < .001). The mean (SD) second systolic blood pressure measured was higher among males
compared with females (153.5 [20.2] mm Hg vs 151.3 [20.9] mm Hg; P < .001), but mean diastolic
blood pressure levels were similar between the groups.
Table 2 outlines the unadjusted baseline 37-day retention rates between the registration visit
and the first follow-up visit overall and by sex and area council. The mean unadjusted 37-day
retention rate was 36% (95% CI, 35%-37%) and was similar between males and females. In the Bwari
area, females had a higher retention rate compared with males (33% [95% CI, 30%-36%] vs 26%
[95% CI, 22%-30%]; P = .01), but rates were similar between males and females in other area
councils.
The 3-month rolling average 37-day retention rate between the registration visit and the first
follow-up visit for patients with hypertension in PHCs in the Federal Capital Territory of Nigeria was
41% (95% CI, 37%-46%), with wide variability among sites (retention rate intraclass correlation
coefficient, 0.24) (Figure 1).
eTable 2 in the Supplement shows the characteristics of retention patterns in hypertension care
by area council. Among all eligible patients, 35.7% returned to PHCs within 37 days, 14.6% returned
between 37 and 90 days, 5.3% returned between 91 and 180 days, 2.7% returned between 181 and
365 days, and 0.6% returned after 365 days. The median time elapsed between the registration visit
and the first follow-up visit for all the patients was 39 days (IQR, 32-62 days). The median time
elapsed between the first and second visit for those who did not return within 37 days was 74 days
(IQR, 53-125 days).
eTable 3 in the Supplement presents the characteristics of staff by area council. The total
number of staff was 1007, including 549 full-time and 458 part-time staff. The median number of
staff per PHC was 12 (IQR, 7-23), the median number of registered patients per PHC was 177.5 (IQR,
109.0-223.5), and the median number of patients per staff member was 10.5 (IQR 7.0-20.0).
Figure 2 shows the interrupted time series regression model with level change adjusted for
seasonality. The adjusted root-mean-square error of the model was 0.04. Although the 37-day
retention rate modestly decreased overall from January to December 2020, retention increased
after the implementation of the WHO HEARTS package from December 2020 (25.6%; 95% CI,
22.1%-30.2%) to July 2021 (48.5%; 95% CI, 44.3%-52.7%) (P < .001). The nonlinear trend revealed
a potential pattern of seasonality, with higher retention rates after baseline visits in the second
quarter of the calendar year compared with other quarters.
Table 3 shows the logistic regression results. The 37-day retention rate was higher among
patients who were older (adjusted odds ratio [aOR], 1.01 per year; 95% CI, 1.01-1.02 per year), were
female (aOR, 1.11; 95% CI, 1.01-1.23), had a higher body mass index (aOR, 1.01; 95% CI, 1.00-1.02),

Table 2. Unadjusted Baseline 37-Day Retention Rates Between the Registration Visit
and the First Follow-up Visit Overall and by Sex and Area Council
37-d Retention rate (95% CI)a
Area council

Total

Males

Females

P value

Abaji

0.39 (0.37-0.42)

0.41 (0.37-0.45)

0.39 (0.36-0.42)

.45

Abuja municipal area council

0.30 (0.28-0.31)

0.28 (0.25-0.31)

0.30 (0.28-0.32)

.32

Bwari

0.31 (0.28-0.33)

0.26 (0.22-0.30)

0.33 (0.30-0.36)

.01

Gwagwalada

0.38 (0.36-0.40)

0.37 (0.33-0.41)

0.39 (0.36-0.41)

.44

Kuje

0.52 (0.48-0.55)

0.54 (0.48-0.60)

0.51 (0.46-0.55)

.38

Kwali

0.38 (0.35-0.41)

0.36 (0.32-0.41)

0.39 (0.35-0.43)

.48

Total

0.36 (0.35-0.37)

0.35 (0.34-0.37)

0.36 (0.35-0.37)

.52

a
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were treated in the Kuje area council compared with the Abaji area council (aOR, 2.25; 95% CI,
1.25-4.04), received blood pressure–lowering treatment at the registration visit (aOR, 1.27; 95% CI
1.07-1.50), and registered during the postintervention period (aOR, 1.16; 95% CI, 1.06-1.26). Patients
who received a new diagnosis of hypertension at their registration were less likely to return within
37 days (aOR, 0.82; 95% CI, 0.74-0.90). The number of staff and number of patients per staff
member were not associated with the 37-day retention rate.

Discussion
Summary of Results
This study evaluated retention in hypertension care and was embedded in the HTN Program, which
is the largest facility-based hypertension program of care in Nigeria and in Africa. The 3-month rolling

Figure 1. Three-Month Rolling Average 37-Day Retention Rate Between the Registration Visit and First Follow-up Visit for Patients With Hypertension
in Primary Health Care Centers in the Federal Capital Territory of Nigeria
1.0
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Inner horizontal lines of the boxes indicate medians; outer horizontal lines of the boxes, interquartile ranges; and whiskers, 95% CIs. The FCT numbers are the study identification
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Figure 2. Interrupted Time Series With Level Change Regression Model Adjusted for Seasonality
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Table 3. Mixed-Effects, Multivariable Logistic Regression Models to Evaluate Factors Associated With a 37-Day
Retention Rate Between the Registration Visit and the First Follow-up Visit

Variable

Model 1, unadjusted OR
(95% CI)

Age, per year

1.01 (1.01-1.02)

Adjusted OR (95% CI)
Model 2a

Model 3b

1.01 (1.01-1.02)

1.01 (1.01-1.02)

1.11 (1.01-1.23)

Sex
Female

1.03 (0.94-1.12)

1.10 (1.01-1.20)

Male

1 [Reference]

1 [Reference]

1 [Reference]

1.01 (1.00-1.01)

1.01 (1.00-1.01)

1.01 (1.00-1.02)

Preexisting diagnosis

1 [Reference]

1 [Reference]

1 [Reference]

New diagnosis at registration

0.76 (0.71-0.83)

0.80 (0.74-0.87)

0.82 (0.74-0.90)

No

1 [Reference]

1 [Reference]

1 [Reference]

Yes

1.12 (0.94-1.33)

1.01 (0.85-1.21)

1.01 (0.83-1.22)

Noncurrent

1 [Reference]

1 [Reference]

1 [Reference]

Current

1.01 (0.81-1.24)

1.03 (0.83-1.28)

0.86 (0.68-1.08)

No

1 [Reference]

1 [Reference]

1 [Reference]

Yes

0.98 (0.89-1.08)

0.95 (0.86-1.04)

1.05 (0.94-1.17)

BMI, per unit
Hypertension

History of diabetes

Alcohol use

Use of fixed-dose combination therapyc

Educational leveld
Never attended school

1 [Reference]

1 [Reference]

1 [Reference]

Primary school

0.82 (0.73-0.92)

0.87 (0.77-0.98)

0.99 (0.87-1.13)

Secondary school

0.67 (0.60-0.75)

0.76 (0.68-0.86)

0.96 (0.84-1.10)

High school or more

0.77 (0.70-0.86)

0.86 (0.77-0.96)

0.99 (0.87-1.12)

Abaji

1 [Reference]

1 [Reference]

1 [Reference]

Abuja municipal area council

0.65 (0.58-0.73)

0.70 (0.62-0.79)

0.71 (0.43-1.17)

Bwari

0.68 (0.58-0.78)

0.71 (0.62-0.83)

0.59 (0.33-1.05)

Area council

Gwagwalada

0.95 (0.84-1.09)

0.99 (0.87-1.13)

1.22 (0.72-2.08)

Kuje

1.66 (1.40-1.96)

1.71 (1.45-2.03)

2.25 (1.25-4.04)

Kwali

0.95 (0.82-1.11)

1.00 (0.86-1.17)

1.05 (0.60-1.83)

No

1 [Reference]

1 [Reference]

1 [Reference]

Yes

1.39 (1.19-1.63)

1.36 (1.17-1.59)

1.27 (1.07-1.50)

1 [Reference]

1 [Reference]

1 [Reference]

BP treatment at registration visite

BP control at registration visit
No

1.05 (0.93-1.18)

0.99 (0.88-1.12)

0.98 (0.86-1.12)

Staff members, including part-time

Yes

0.99 (0.99-1.00)

0.99 (0.99-1.00)

0.99 (0.98-1.00)

Patients per staff member

1.00 (0.99-1.00)

1.00 (0.99-1.00)

0.99 (0.98-1.01)

Postintervention period registration

1.13 (1.04-1.23)

1.11 (1.02-1.21)

1.16 (1.06-1.26)

Generalist MDs

0.88 (0.86-0.90)

0.89 (0.86-0.91)

0.89 (0.79-0.99)

Specialist MDs

0.97 (0.94-0.99)

0.96 (0.94-0.99)

0.95 (0.82-1.10)

Nonphysician clinicians or
paramedical professionals

1.42 (1.23-1.63)

1.39 (1.20-1.60)

1.34 (0.72-2.51)

Staff type

Nursing professionals

1.00 (0.99-1.01)

1.00 (0.99-1.01)

0.99 (0.94-1.04)

Pharmacists

0.79 (0.74-0.85)

0.79 (0.73-0.84)

0.81 (0.57-1.15)

Laboratory technicians

0.97 (0.96-0.98)

0.97 (0.96-0.98)

0.97 (0.92-1.02)
(continued)
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Table 3. Mixed-Effects, Multivariable Logistic Regression Models to Evaluate Factors Associated With a 37-Day
Retention Rate Between the Registration Visit and the First Follow-up Visit (continued)

Variable

Model 1, unadjusted OR
(95% CI)

Adjusted OR (95% CI)
Model 2a

Model 3b

Community health extension workers

0.98 (0.97-0.99)

0.98 (0.97-0.99)

0.98 (0.95-1.02)

Junior community health extension
workers

0.99 (0.98-0.99)

0.99 (0.98-0.99)

0.98 (0.94-1.01)
0.98 (0.96-1.01)

Community volunteers

0.99 (0.98-0.99)

0.99 (0.98-0.99)

Community health officers

0.82 (0.78-0.85)

0.82 (0.79-0.86)

0.85 (0.71-1.03)

Otherf

1.00 (1.00-1.01)

1.00 (1.00-1.01)

1.00 (0.98-1.03)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); BP, blood
pressure; OR, odds ratio.
a

Adjusted for age and sex.

b

Adjusted for age, sex, BMI, alcohol use, fixed-dose combination therapy, educational level, and primary health care
center (random effect).

c

Fixed-dose combination therapy at the start of the baseline visit (ie, walk-in period).

d

P < .001 for trend across levels of education for 37-day retention rate.

e

Defined as patients who received treatment when they completed the clinical visit, including patients who continued
treatment or were newly treated.

f

Other staff include health attendants, medical record officers, security workers, and cleaners.

average retention rate for the registration visit and the first follow-up visit was 41% across 60 public
PHCs in the Federal Capital Territory, and wide variability among PHCs was observed. The median
duration between the registration visit and the first follow-up visit for all the patients was 39 days but
was approximately 2.5 months (74 days) among those who did not return within 37 days. Patients
had low levels of education and low rates of smoking and comorbid diseases. Patients who were
older, were female, and/or had a higher body mass index were more likely to have a higher retention
rate. In addition, receiving blood pressure–lowering treatment during the first visit was also
associated with a higher retention rate, suggesting the importance of initial treatment and an
association of initial treatment with follow-up in the cascade of hypertension care.
The pattern of short-term retention showed seasonal differences, with higher retention rates
after baseline visits in the second quarter of the calendar year compared with other quarters.
Furthermore, although the 37-day retention rate modestly decreased in 2020, likely owing to the
COVID-19 pandemic, retention increased after the implementation of the WHO HEARTS package
starting in December 2020, which included the provision of free blood pressure–lowering
medications to patients in January 2021. Although it is not feasible to directly infer a causal
relationship, these results suggest that implementation of the WHO HEARTS package is associated
with improved retention in hypertension care. Future research is needed to explore the findings
observed in the interrupted time series pattern.
Retention rates also differed among and within the 6 area councils, including between sexes
and among PHC staffing levels. For example, in Bwari, females had a significantly higher retention
rate compared with males, which might be attributable to the geographic and sociodemographic
differences in this area. Furthermore, Kuje had the highest retention rate; however, the median
number of staff members per PHC in this area was 8, which was lower than the median of 12 staff
members per PHC across all areas. Possible reasons for the higher retention rate include the
following: (1) Kuje’s staff commitment may have been higher than that in the other areas; (2) Kuje had
a stricter quarantine policy after the COVID-19 pandemic than did the other area councils, and
patients may have received care only within their community, which may have increased local
primary health care visit frequency and thus retention; and (3) most health care workers lived in the
same community where the PHCs were located, were already familiar with the patients, and often
reminded the patients about follow-up visits. However, there may be a threshold below which fewer
staff members would be associated with reduced retention. Patients who registered after the
JAMA Network Open. 2022;5(9):e2230025. doi:10.1001/jamanetworkopen.2022.30025 (Reprinted)
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intervention period had a higher retention rate; this finding suggests that the HTN Program was
associated with improved short-term retention.

Results in Context
These results revealed potentially modifiable and nonmodifiable patient, site, area council, and
temporal factors that may be associated with differences in retention. Potentially modifiable factors
include the provision of free hypertension treatment and the implementation of the WHO HEARTS
technical package. Other potentially modifiable factors that were not measured, such as distance to
the PHC and operating hours, might be associated with retention. Health systems in low- and
middle-income countries also have lower universal health coverage rates for noncommunicable
disease care compared with coverage for maternal, neonatal, nutritional, and communicable
diseases; this lack of coverage may further limit retention in hypertension care.26
The low level of short-term retention reported in the current study may be expected. Studies in
low- and middle-income countries have shown even lower levels of follow-up or adherence to clinic
appointments. For example, a 2018 study in Kenya reported that only 21% of patients with
hypertension had follow-up visits within 6 months, and 63% of those patients were adherent to
clinical appointments after the follow-up visits.27 A study in Malawi showed that 47% of patients with
hypertension had at least 1 follow-up visit within 24 months.28 Similar to our findings, that study
found retention in care to be higher among older and female patients. The Community-based
Hypertension Improvement Project cohort study in Ghana reported that 41% of patients with
hypertension had follow-up visits at 6 months, and 25% continued to retain hypertension care at 12
months.29 Studies that used longer time horizons (eg, 6 or 12 months) may have reported higher
retention rates, but longer time horizons often do not match clinical care models wherein patients
are provided 1-month supplies of blood pressure–lowering medications.
Patient retention may be limited by patients’ circumstantial, geographic, and financial access to
health care, the perception of the disease processes and patients’ care needs, and external factors
such as the COVID-19 pandemic.11 Losing patients to follow-up at the retention step of the
hypertension care cascade negates the work of all other previous steps, including accurate diagnosis
and treatment.30 Low availability and cost of medications may deter patients from returning to
clinics.31 Retention rates in this study improved after HEARTS implementation, which included the
provision of free medications; however, retention rates remained suboptimal. Treatment-seeking
and management behavior may be further associated with social and religious constructs, such as
gender inequity in treatment decision-making, lack of awareness of causes and treatment models,
and reliance on herbal and traditional remedies.32
Interventions to improve retention have been tested with generally modest effect sizes, but
they typically operate only at a single level (eg, patient, practitioner, or facility). For example,
behavioral communication-based hypertension educational tools have been shown to be associated
with an increase in the retention rate of 9% at 6 months.33 Furthermore, a study in Kenya showed
that integrated and colocated chronic disease care was associated with an increase in the retention
rate of 10.5% over 6 months,34 and mobile health messaging increased the retention rate by 10%.35
These findings suggest that multilevel interventions such as the WHO HEARTS package may be
effective and can potentially address circumstances in which patients’ needs change over time and
risk factors, diseases, and health resources are in a continuous state of interaction and flux congruent
with complexity models.
Despite the importance of retention in the hypertension care cascade, it is uncertain which
strategies are most effective in improving retention and in which contexts. Addressing practitionerpatient communication, financial barriers, and education has been shown to be effective in
improving retention.36,37 A project that includes a systematic review of interventions to improve
retention is under way,38 as well as a community participatory research study that will incorporate
stakeholder perspectives in Nigeria (ie, patients, community health extension workers, nurses,
pharmacists, researchers, administrators, policy makers, and physicians).
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Strengths and Limitations
This study has several strengths. The study collected high-quality data from PHC settings in Nigeria
that had not previously conducted hypertension research and included data during the COVID-19
pandemic. The study also included longitudinal follow-up of a large number of patients from a large
number of sites at the primary health care level, where most care in Nigeria is delivered. In addition,
the study addressed retention, which is an essential but understudied aspect of longitudinal, highquality hypertension care.
This study also has limitations. First, although the PHCs were sampled using a multistage
probability approach to represent care in the Federal Capital Territory, the results may not be
generalizable to other states in Nigeria or countries outside Nigeria. Second, although the trained
study staff were instructed to use the audit and feedback reports to optimize patient retention, the
fidelity of the report used may have been lower in some PHCs than in others. Nevertheless, the study
team performed quarterly site-level monitoring and supportive supervision visits to assist in the
facilitation activities, including training and education, with real-time feedback to address the
barriers to the study procedures, including review of the audit and feedback reports. Third, despite
efforts to optimize data quality, including biweekly data status and quality reporting, there were
some missing or low-quality data that needed to be excluded. However, the proportion of patients
excluded was small (3.5%) and thus not likely to influence the validity of the results. Fourth, we were
limited in our ability to understand how the COVID-19 pandemic may have influenced the retention
rate, which was beyond the scope of this study. The Delta wave was observed in Nigeria between
early December 2020 and early March 2021 (the peak was late January 2021). Although there is
some overlap with this wave and the nadir of retention in the current study (October to December
2020), lower retention was observed before the Delta variant was widely observed. However, some
patients may have been ill with COVID-19 before the observed Delta wave based on confirmatory
test data. Future research planned by the study team includes the qualitative exploration of factors,
such as the COVID-19 pandemic, that may be associated with retention among stakeholders,
including patients. Future research is needed to explore the findings observed in the interrupted time
series pattern.

Conclusions
The findings of this study suggest that short-term retention in hypertension care is suboptimal and
widely variable across the PHCs in the Federal Capital Territory of Nigeria. We identified potentially
modifiable and nonmodifiable factors associated with retention. Because of the burden of
hypertension, evidence-based strategies for improving retention in hypertension care at the primary
health care level are needed to improve hypertension management in Nigeria and likely in other
settings.
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